{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T07:49:21Z","timestamp":1777362561229,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["2010-0001284"],"award-info":[{"award-number":["2010-0001284"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002462","name":"Chungnam National University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002462","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.vaccine.2010.09.083","type":"journal-article","created":{"date-parts":[[2010,10,11]],"date-time":"2010-10-11T10:47:22Z","timestamp":1286794042000},"page":"7873-7880","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Mycobacterial cell-wall skeleton as a universal vaccine vehicle for antigen conjugation"],"prefix":"10.1016","volume":"28","author":[{"given":"Tae-Hyun","family":"Paik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Sook","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki-Hye","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chul-Su","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun-Kyeong","family":"Jo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Hwa","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2010.09.083_bib0005","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1023\/A:1016104910582","article-title":"Recent advances in vaccine adjuvants","volume":"19","author":"Singh","year":"2002","journal-title":"Pharm Res"},{"issue":"23","key":"10.1016\/j.vaccine.2010.09.083_bib0010","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1016\/S0264-410X(03)00256-1","article-title":"Immunization with recombinant Calmette-Guerin bacillus &LPKT;BCG&RPKT;-hepatitis C virus &LPKT;HCV&RPKT; elicits HCV-specific cytotoxic T lymphocytes in mice","volume":"21","author":"Uno-Furuta","year":"2003","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2010.09.083_bib0015","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1586\/14760584.6.5.785","article-title":"Cationic liposomes as vaccine adjuvants","volume":"6","author":"Christensen","year":"2007","journal-title":"Expert Rev Vaccines"},{"issue":"7198","key":"10.1016\/j.vaccine.2010.09.083_bib0020","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nature06939","article-title":"Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants","volume":"453","author":"Eisenbarth","year":"2008","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.vaccine.2010.09.083_bib0025","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.4049\/jimmunol.180.8.5402","article-title":"The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells","volume":"180","author":"Seubert","year":"2008","journal-title":"J Immunol"},{"issue":"27\u201328","key":"10.1016\/j.vaccine.2010.09.083_bib0030","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1016\/j.vaccine.2004.03.032","article-title":"Aluminium adjuvants \u2013 in retrospect and prospect","volume":"22","author":"Lindblad","year":"2004","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2010.09.083_bib0035","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.vaccine.2008.11.112","article-title":"Development of effective vaccines for old mice in a tumor model","volume":"27","author":"Posnett","year":"2009","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2010.09.083_bib0040","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/CJI.0b013e3181829f62","article-title":"Lysates of S. pyogenes serotype M49 induce pancreatic tumor growth delay by specific and unspecific antitumor immune responses","volume":"31","author":"Linnebacher","year":"2008","journal-title":"J Immunother"},{"issue":"3","key":"10.1016\/j.vaccine.2010.09.083_bib0045","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0264-410X(96)00183-1","article-title":"Adjuvants \u2013 a classification and review of their modes of action","volume":"15","author":"Cox","year":"1997","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2010.09.083_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2567.2001.01236.x","article-title":"The many faces of host responses to tuberculosis","volume":"103","author":"Collins","year":"2001","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.vaccine.2010.09.083_bib0055","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tube.2004.10.001","article-title":"Cell wall lipids from Mycobacterium bovis BCG are inflammatory when inoculated within a gel matrix: characterization of a new model of the granulomatous response to mycobacterial components","volume":"85","author":"Rhoades","year":"2005","journal-title":"Tuberculosis"},{"issue":"9","key":"10.1016\/j.vaccine.2010.09.083_bib0060","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2010.09.083_bib0065","doi-asserted-by":"crossref","first-page":"S353","DOI":"10.1093\/clinids\/11.Supplement_2.S353","article-title":"The BCG story: lessons from the past and implications for the future","volume":"11","author":"Fine","year":"1989","journal-title":"Rev Infect Dis"},{"issue":"9517","key":"10.1016\/j.vaccine.2010.09.083_bib0070","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2010.09.083_bib0075","first-page":"9","article-title":"Toll-like receptor signaling in anti-cancer immunity","volume":"50","author":"Okamoto","year":"2003","journal-title":"J Med Invest"},{"issue":"12","key":"10.1016\/j.vaccine.2010.09.083_bib0080","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.1128\/IAI.68.12.6883-6890.2000","article-title":"Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guerin: involvement of toll-like receptors","volume":"68","author":"Tsuji","year":"2000","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2010.09.083_bib0105","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S1367-5931(97)80055-5","article-title":"The mycobacterial cell wall: structure, biosynthesis and sites of drug action","volume":"1","author":"Chatterjee","year":"1997","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.vaccine.2010.09.083_bib0110","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.bi.64.070195.000333","article-title":"The envelope of mycobacteria","volume":"64","author":"Brennan","year":"1995","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"10.1016\/j.vaccine.2010.09.083_bib0145","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/jnci\/52.1.95","article-title":"Biologically active components from mycobacterial cell walls. I. Isolation and composition of cell wall skeleton and component P3","volume":"52","author":"Azuma","year":"1974","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.vaccine.2010.09.083_bib0115","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S1567-5769(01)00055-8","article-title":"Development of immunoadjuvants for immunotherapy of cancer","volume":"1","author":"Azuma","year":"2001","journal-title":"Int Immunopharmacol"},{"issue":"00","key":"10.1016\/j.vaccine.2010.09.083_bib0120","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1749-6632.1976.tb41699.x","article-title":"Immunotherapy of cancer with cell wall skeleton of Myocabacterium bovis-Bacillus Calmette-Guerin: experimental and clinical results","volume":"277","author":"Yamamura","year":"1976","journal-title":"Ann NY Acad Sci"},{"issue":"3","key":"10.1016\/j.vaccine.2010.09.083_bib0125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF00205355","article-title":"Postoperative adjuvant immunotherapy of gastric cancer with BCG-cell wall skeleton 3- to 6-year follow up of a randomized clinical trial","volume":"14","author":"Ochiai","year":"1983","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.vaccine.2010.09.083_bib0090","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1749-6632.1995.tb44453.x","article-title":"Progress on development of the live BCG recombinant vaccine vehicle for combined vaccine delivery","volume":"754","author":"Hanson","year":"1995","journal-title":"Ann NY Acad Sci"},{"issue":"11","key":"10.1016\/j.vaccine.2010.09.083_bib0130","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.1128\/IAI.00322-07","article-title":"Effects of DNA- and Mycobacterium bovis BCG-based delivery of the Flt3 ligand on protective immunity to Mycobacterium tuberculosis","volume":"75","author":"Triccas","year":"2007","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2010.09.083_bib0135","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.vaccine.2007.10.052","article-title":"Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge","volume":"26","author":"Seixas","year":"2007","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2010.09.083_bib0140","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1128\/IAI.71.8.4238-4249.2003","article-title":"Simultaneous blocking of human Toll-like receptors 2 and 4 suppresses myeloid dendritic cell activation induced by Mycobacterium bovis bacillus Calmette-Guerin peptidoglycan","volume":"71","author":"Uehori","year":"2003","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2010.09.083_bib0210","doi-asserted-by":"crossref","first-page":"7224","DOI":"10.1074\/jbc.275.10.7224","article-title":"Cell wall structure of a mutant of Mycobacterium smegmatis defective in the biosynthesis of mycolic acids","volume":"275","author":"Wang","year":"2000","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.vaccine.2010.09.083_bib0150","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1248\/cpb.55.843","article-title":"Study on the cell wall skeleton derived from Mycobacterium bovis BCG Tokyo 172 &LPKT;SMP-105&RPKT;: establishment of preparation and analytical methods","volume":"55","author":"Uenishi","year":"2007","journal-title":"Chem Pharm Bull"},{"issue":"48\u201349","key":"10.1016\/j.vaccine.2010.09.083_bib0155","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1016\/j.vaccine.2005.07.036","article-title":"Relationship between haemolytic and adjuvant activity and structure of protopanaxadiol-type saponins from the roots of Panax notoginseng","volume":"23","author":"Sun","year":"2005","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2010.09.083_bib0160","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0169-409X(98)00008-8","article-title":"Aluminum compounds as vaccine adjuvants","volume":"32","author":"Gupta","year":"1998","journal-title":"Adv Drug Deliv Rev"},{"issue":"13","key":"10.1016\/j.vaccine.2010.09.083_bib0165","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1016\/j.molimm.2008.05.010","article-title":"Molecular differences between the divergent responses of ovalbumin-specific CD4 T cells to alum-precipitated ovalbumin compared to ovalbumin expressed by Salmonella","volume":"45","author":"Serre","year":"2008","journal-title":"Mol Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2010.09.083_bib0170","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00262-002-0309-z","article-title":"Adjuvants and the promotion of Th1-type cytokines in tumour immunotherapy","volume":"51","author":"Dredge","year":"2002","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.vaccine.2010.09.083_bib0175","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.1016\/j.vaccine.2005.06.024","article-title":"TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod &LPKT;R-848&RPKT;","volume":"23","author":"Weeratna","year":"2005","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2010.09.083_bib0180","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4049\/jimmunol.170.1.194","article-title":"Toll-like receptor 2 ligands as adjuvants for human Th1 responses","volume":"170","author":"Sieling","year":"2003","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2010.09.083_bib0185","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/nri706","article-title":"A role for antigen in the maintenance of immunological memory","volume":"2","author":"Gray","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2010.09.083_bib0190","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1128\/CMR.15.2.294-309.2002","article-title":"Innate immunity to Mycobacterium tuberculosis","volume":"15","author":"van Crevel","year":"2002","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2010.09.083_bib0195","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1128\/IAI.72.2.937-948.2004","article-title":"Mycobacterium bovis BCG cell wall-specific differentially expressed genes identified by differential display and cDNA subtraction in human macrophages","volume":"72","author":"Begum","year":"2004","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2010.09.083_bib0200","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/ni1138","article-title":"Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T&LPKT;H&RPKT;1 priming","volume":"5","author":"Martin-Fontecha","year":"2004","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2010.09.083_bib0205","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cpsurg.2003.08.001","article-title":"Immunotherapy of surgical malignancies","volume":"41","author":"Morse","year":"2004","journal-title":"Curr Probl Surg"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10014258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10014258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:17:17Z","timestamp":1759400237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10014258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":39,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0264410X10014258"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.09.083","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mycobacterial cell-wall skeleton as a universal vaccine vehicle for antigen conjugation","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.09.083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}